Schmalzing Marc

24PUBLICATIONS
83CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersHaematologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and Physicians.

|Apr 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis.

|Dec 02, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience.

Michael Gernert, Jörg Henes, Patrick-Pascal Strunz

|Nov 18, 2025
Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety.

Marc Schmalzing, Ayman Askari, Giampiero Girolomoni

|Jul 09, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors.

Sebastian Hüper, Florian Eisele, Johannes Duell

|Apr 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht

Pageof 4

Frequent Collaborators

12 joint publications

Patrick-Pascal Strunz

12 joint publications

Michael Gernert

9 joint publications

Matthias Fröhlich

7 joint publications

Labinsky Hannah